#Uk regulation

2 stories

Regulatory April 8, 2026 · View digest

UK MHRA Probes Peptide Clinics Over Unlawful BPC-157 and MOTS-C Health Claims

The UK's MHRA is investigating peptide clinics promoting BPC-157, MOTS-C, and Cortexin with unproven claims. Making medicinal claims classifies these products as medicines under UK law.

Regulatory April 7, 2026 · View digest

UK MHRA Launches Investigation into Peptide Clinics Making Medicinal Claims

The UK's medicines regulator is investigating whether clinics are breaking the law by making unsubstantiated medicinal claims for unregulated peptide therapies.